Lohman Technologies Appoints Renowned Heart Surgeon Dr. Eric S. Weiss to Board of Directors
- Lohman Tech
- 2 days ago
- 2 min read
Board expansion accelerates commercialization pipeline of AI-Enabled Remote Cardiac Care
MILWAUKEE, WI. (April 27, 2026) Lohman Technologies (www.homECG.com), announced today that Dr. Eric S. Weiss, MD, MPH, President of Cardiovascular & Thoracic Surgery and Co-Director of Valve Surgery at Mount Sinai Medical Center in Miami Beach, Florida, has joined its Board of Directors. This appointment further bolsters the company’s leadership as it accelerates commercialization of its AI-enabled remote cardiac monitoring platform.
Lohman’s proprietary HomECG+ platform delivers FDA-cleared clinical-grade ECG technology, explainable AI analytics, and cloud-based care coordination to support continuity of cardiac care. Building on the success of AfibAlert — the first FDA-cleared handheld atrial fibrillation detection device — Lohman continues to lead in portable cardiac diagnostics and health equity.
"Consumer devices have raised awareness, but they don’t solve the clinical problem."
-- Dr. Eric S. Weiss, MD, MPH

Dr. Eric S. Weiss, MD, MPH, noted, “One of the biggest gaps in cardiac care is what happens after the patient leaves the hospital. We perform complex procedures, but too often lose meaningful visibility once they go home. Consumer devices have raised awareness, but they don’t solve the clinical problem. What’s needed is reliable, physician-directed visibility into patients after discharge, and platforms like this have the potential to meaningfully improve how we manage patients beyond the hospital.”
“I’m pleased to share yet another solid addition to our Board of Directors,” said Jason Dvorak, President of Lohman Technologies. “Dr. Weiss brings significant credibility to our validity in the marketplace and will assist with our direction as we ramp our commercial efforts.”
Craig Schiefelbein, Chairman, added, “Bringing world-class clinical expertise to the board is essential as we scale responsibly. Dr. Weiss’s surgical leadership and deep understanding of cardiac care delivery will help guide strategic partnerships with enterprise health systems and RPM providers while maintaining focus on innovation and operational excellence.”
A nationally recognized cardiothoracic surgeon who has performed over 6,000 heart surgeries, Dr. Weiss specializes in complex adult cardiac procedures, including minimally invasive valve repair and replacement, aortic surgery, and advanced heart failure treatments. His leadership roles and commitment to improving patient outcomes align closely with Lohman’s mission to deliver proactive, accessible, and longitudinal cardiac care.
About Lohman Technologies
Lohman’s patented solution, HomECG+, offers a direct connection between the patient and their healthcare providers, eliminating the need for a smartphone or WIFI technology. This not only enhances efficiency but also expands access to cardiac monitoring services. Visit www.homecg.com for more information.